Background Uncertainty surrounds the usefulness of inflammatory markers in hepatocellular
carcinoma (HCC) patients for predicting postoperative pulmonary metastasis (PM). The …

Background: Pulmonary metastasis (PM) following curative hepatectomy for hepatocellular
carcinoma (HCC) is indicative of a poor prognosis. This study aimed to develop a nomogram …

A novel prognostic nomogram predicting post-transplant pulmonary metastasis was
established with a primary cohort of 308 HCC patients who received liver transplantation …

In some areas where routine screening for hepatocellular carcinoma is not available, 30% of
HCC patients present with extra-hepatic metastases at the first visit. The most common …

Background Only a few studies have investigated the clinical features and outcomes of
patients with pulmonary metastasis from hepatocellular carcinoma (HCC) at the initial …

Background The prognosis for patients with hepatocellular carcinoma (HCC) after liver
resection ranges widely and is unsatisfactory. This study aimed to develop two novel …

Background: Mounting studies reveal the relationship between inflammatory markers and
post-therapy prognosis, yet the role of the systemic inflammatory indices in preoperative …

Background Preoperative serum inflammatory markers have been correlated with survival
outcomes after resection of hepatocellular carcinoma (HCC). Whether they can predict …

Background: This study developed a novel inflammation score system to predict survival
outcomes using preoperational inflammatory markers in hepatocellular carcinoma (HCC) …

Purpose Hepatocellular carcinoma (HCC) is an aggressive disease with high recurrence
rate. However, current staging systems were lack of predictive capacity for HCC recurrence …